Deferasirox
NDC 70700-271, Deferasirox, tablet, from Xiromed, LLC.
- Product NDC
- 70700-271
- Status
- Listed
- Labeler
- Xiromed, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212995
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70700-271 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFERASIROX360 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70700-271-30 | 70700027130 | 30 TABLET in 1 BOTTLE, PLASTIC (70700-271-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4c36bb5a-2552-46c1-8500-4ae783cffef1NADAC price for package 70700027130
GET /v1/drugs/nadac/70700027130
Use it
Look up 70700-271 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70700-271 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70700-271. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.